close
close

Valsoft enters the life sciences sector with the acquisition of Anju Software


Valsoft enters the life sciences sector with the acquisition of Anju Software

MONTREAL, QC / ACCESSWIRE / August 29, 2024 / Valsoft Corporation Inc. (“Valsoft”), a Canadian company specializing in the acquisition and development of software companies for vertical markets, is pleased to announce the acquisition of Anju Software (“Anju”), the global pioneer in customized life science solutions for clinical research, medical affairs and data science.

Anju is a customer-centric company that offers customizable solutions that provide customers with an excellent experience in simplifying the complexity of information management in life sciences. The company’s flagship products, TrialMaster, IRMS MAX and TA Scan, reduce the complexity of the drug and device discovery and commercialization process and enable customers to improve the quality of life of their patients.

“Our mission is to always be a customer-centric company, driven by a passionate team, providing the best value-added life science solutions,” explains Laurence P. Birch, CEO of Anju. “In Valsoft, we have found a partner with a similar long-term growth vision that will enable us to further expand our expertise in the life sciences field.”

“Anju’s consistent global growth and customer satisfaction are a clear reflection of the team’s hard work and dedication over the years,” said Sam Youssef, CEO of Valsoft. “We aim to preserve the strong legacy Anju has built in life sciences while continuing to develop innovative technologies for existing and new customers.”

Anju solutions are used by large, mid-sized and small pharmaceutical companies, clinical research organizations (CROs) and medical device manufacturers, as well as full-service medical marketing, market research and communications agencies. Their technologies facilitate the flow of data between Anju software solutions and seamless communication with third-party systems, providing their clients with a unique way to leverage critical information and achieve impactful results.

Anju is Valsoft’s first acquisition of a life sciences company. With Valsoft’s support, Anju is well positioned to increase its market presence while continuing to provide unparalleled cost-effective solutions.

Information Anju
Anju Software is a customer-focused company that provides customizable life science solutions for clinical research, medical affairs and data science. TrialMaster, IRMS MAX and TA Scan, the company’s flagship products, are leaders in reducing complexity in the drug and device discovery and commercialization process. Anju is a portfolio company of Valsoft Corporation serving the global pharmaceutical, biotechnology and life science contract research markets.

About Valsoft Corporation
Valsoft acquires and develops vertical market software companies that deliver mission-critical solutions. A core tenet of the Valsoft philosophy is to invest in established companies and foster an entrepreneurial environment that makes a company a leader in its respective industry. Unlike private equity and VC firms, Valsoft has no predefined investment horizon and seeks to buy, hold and create value through long-term partnerships with existing management and customers. For more information: www.valsoftcorp.com

Valsoft was represented internally by David Felicissimo, General Counsel, Shinjay (Ssin) Choi (Senior Legal Counsel) and externally by Steven M. Peck of Proskauer Rose. Anju was represented by Kirkland & Ellis LLP.

Media contact information:
Communication and public relations
Valsoft Corporation
(email protected)

SOURCE: Valsoft Corp

Leave a Reply

Your email address will not be published. Required fields are marked *